Construction and validation of an IRF4 risk score to predict prognosis and response to immunotherapy in hepatocellular carcinoma
Open Access
- 8 November 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 113 (Pt A) , 109411
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Department of Sichuan Province (2019YFG0036, 2019YFS0204)
- Sichuan University
- West China Hospital, Sichuan University (ZY2017308)
- National Natural Science Foundation of China (82070674)
This publication has 45 references indexed in Scilit:
- The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2Immunobiology, 2018
- Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinomaJournal of Biological Chemistry, 2017
- Transcription Factor IRF4 Promotes CD8+ T Cell Exhaustion and Limits the Development of Memory-like T Cells during Chronic InfectionImmunity, 2017
- CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignanciesBlood, 2017
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint BlockadeCell Reports, 2017
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human CancerImmunity, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- Interferon Regulatory Factor (IRF)-1 and IRF-2 are Associated with Prognosis and Tumor Invasion in HCCAnnals of Surgical Oncology, 2012
- Interferon-gamma induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1)Cancer Letters, 2012
- A random forest approach to the detection of epistatic interactions in case-control studiesBMC Bioinformatics, 2009